Canada to approve DSM biofungicide
The Canadian Pest Management Regulatory Agency (PMRA) has proposed the approval of Dutch nutritional products company DSM’s (Delft) biofungicide, Zivion M (natamycin), for the suppression of dry bubble disease ( Verticillium fungicola) of mushrooms. Natamycin is naturally produced by the soil bacterium, Streptomyces natalensis, and inactivates germinating fungal spores, the PMRA notes. It has a long history as a food additive and is approved as such in more than 70 countries, the Agency. The US EPA granted a tolerance exemption to DSM for natamycin this month. The Canadian registration decision is subject to a 45-day public comment from May 25th.